{"id":"W4213427186","doi":"10.1200/jco.21.00714","title":"Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; AstraZeneca","keywords":"Medicine; Radioactive iodine; Selumetinib; Placebo; Thyroid cancer; Adjuvant; Randomized controlled trial; Oncology; Internal medicine; Cancer; Thyroid; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004577869,0.000335356,0.00667216,0.0003126959,0.0001234756,0.00001339134,0.0002129663,0.0002126903,0.001049939],"category_scores_gemma":[0.001782047,0.0002000872,0.001111415,0.0002844606,0.0002340881,0.00009599781,0.0000804045,0.001917451,0.000002466356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001335268,"about_ca_system_score_gemma":0.002785762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004085571,"about_ca_topic_score_gemma":0.0001770835,"domain_scores_codex":[0.9914793,0.002898803,0.003890025,0.0004027679,0.0009161452,0.0004129459],"domain_scores_gemma":[0.9886332,0.005311231,0.004974612,0.0002474435,0.0003787903,0.0004547867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9306269,0.01977883,0.01773213,0.000007258826,0.004386773,0.0005200962,0.0002175285,0.0005483882,0.000003396825,0.00001383282,0.001944036,0.02422078],"study_design_scores_gemma":[0.8911551,0.07737976,0.0250902,0.00007147562,0.004445164,0.00002683279,0.0001334853,0.0002742994,0.0000134608,0.0000436959,0.001199058,0.0001675089],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879326,0.001370965,0.00004586678,0.002772776,0.002664459,0.004939697,0.00008703041,0.00001503126,0.0001715926],"genre_scores_gemma":[0.9949068,0.001864047,0.000361648,0.0006775493,0.000953227,0.001027867,0.00003605573,0.00003480792,0.0001379495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05760092,"threshold_uncertainty_score":0.9998632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03123279664049053,"score_gpt":0.3837636869297161,"score_spread":0.3525308902892256,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}